This compound is a quinazoline derivative used as an active pharmaceutical ingredient in the production of pharmaceutical products. It is characterized by a complex structure containing multiple aromatic rings and halogen substituents.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 402855-03-2
(S)-N4-(3,4-Difluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine
Pharmaceutical intermediate for afatinib
(S)-N4-(3,4-Dichlorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine
pharmaceutical intermediate for afatinib impurities
(S)-N4-(4-Fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine (Afatinib Impurity)
Afatinib impurity reference standard
Ertapenem Dimer Impurity
Impurity reference standard for Ertapenem
Telaprevir
active pharmaceutical ingredient
6'-N-(Benzyloxycarbonyl)kanamycin A Sulfate
active pharmaceutical ingredient
Parvaquone
veterinary active pharmaceutical ingredient
N4-(3-chloro-4-fluorophenyl)-7-(((3S)-tetrahydro-3-furanyl)oxy)-4,6-quinazolinediamine
active pharmaceutical ingredient metabolite
4-N-(3-chloro-4-fluorophenyl)-7-[(3R)-oxolan-3-yl]oxyquinazoline-4,6-diamine
BIQABKFYKJRXII-LLVKDONJSA-N
C1COC[C@@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)N